Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02038127 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Gangwon PCI Prospective Registry

Study acronym: GWPCI
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary endpoint reworded 1 of 1 changed
See other at-risk trials from Yonsei University

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoint(s) modified Show 8 more changesShow less
    • Enrollment increased: 5000 → 10000 participants
    • Interventions modified
    • Trial arms changed: 0 → 1
    • Study sites: 3 to 4
    • Eligibility criteria shortened, about 199 words
    • Secondary endpoints: 5 to 10
    • Study description expanded, about 198 words
    • Publications: details revised at 3 of 3 entries
  2. 2 versions Re-verified since Jul 22, 2024, no change to tracked fieldsv7-v8
  3. Study title expanded, about 1 wordv6
  4. Primary completion date: Dec 31, 2020 to Dec 31, 2030
    • Study completion date: Dec 31, 2022 to Dec 31, 2031
    v5
  5. Primary completion date: Nov 2017 to Dec 31, 2020
    • Study completion date: Dec 2017 to Dec 31, 2022
    • Start date: Jan 2013 to Jan 1, 2013
    v4
  6. 2 versions Re-verified since Jan 21, 2015, no change to tracked fieldsv2-v3
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This prospective, multicenter registry will consecutively enroll patients of all ages undergoing percutaneous coronary intervention (PCI) at four university hospitals in Gangwon Province, Republic of Korea. The study will describe contemporary clinical, procedural, and medication treatment patterns and assess 1-year clinical outcomes in routine practice. The primary outcome is patient-oriented composite outcome (POCO), defined as all-cause death, any myocardial infarction, or any repeat revascularization. No study-specific intervention will be assigned.
Trial Details
NCT Number NCT02038127
Lead Sponsor Yonsei University
Collaborators: Gangwon Cardiovascular Health Research Institute
Conditions
(from sponsor)		 Coronary Artery Disease, Ischemic Heart Disease (IHD), Unstable Angina (UA), Non-ST Elevated Myocardial Infarction, ST-Elevation Myocardial Infarction, Vasospastic Angina
Related terms Angina Pectoris, Variant, Angina, Unstable, Coronary Artery Disease, Myocardial Ischemia, Non-ST Elevated Myocardial Infarction, ST Elevation Myocardial Infarction
Enrollment 10,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov